BRAF(V600E) Mutations in High Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination Therapy

Neuroendocrine tumors comprise a heterogeneous group of malignancies with a broad spectrum of clinical behavior. Poorly differentiated tumors follow an aggressive course with limited treatment options, and new approaches are needed. Oncogenic BRAF V600E (BRAF(V600E)) substitutions are observed prima...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Discov
Autors principals: Klempner, Samuel J., Gershenhorn, Bruce, Tran, Phu, Lee, Thomas K., Erlander, Mark G., Gowen, Kyle, Schrock, Alexa B., Morosini, Deborah, Ross, Jeffrey S., Miller, Vincent A., Stephens, Philip J., Ignatius Ou, Sai-Hong, Ali, Siraj M.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008024/
https://ncbi.nlm.nih.gov/pubmed/27048246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-15-1192
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars